Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
21.27
+0.29 (1.38%)
At close: Apr 28, 2026, 4:00 PM EDT
21.20
-0.07 (-0.33%)
After-hours: Apr 28, 2026, 7:30 PM EDT
Definium Therapeutics Market Cap
Definium Therapeutics has a market cap or net worth of $2.12 billion as of April 28, 2026. Its market cap has increased by 447.40% in one year.
Market Cap
2.12B
Enterprise Value
1.75B
1-Year Change
447.40%
Ranking
Category
Stock Price
$21.27
Market Cap Chart
Since March 4, 2020, Definium Therapeutics's market cap has increased from $595.37M to $2.12B, an increase of 256.18%. That is a compound annual growth rate of 22.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sarepta Therapeutics | 2.22B |
| Tyra Biosciences | 2.20B |
| Ascentage Pharma Group International | 2.17B |
| Mineralys Therapeutics | 2.15B |
| Adaptive Biotechnologies | 2.14B |
| Aurinia Pharmaceuticals | 2.13B |
| Zymeworks | 2.10B |
| Ocular Therapeutix | 2.09B |